An inverse relationship between peroxisome proliferator-activated receptor γ and allergic airway inflammation in an allergen challenge model

Annals of Allergy, Asthma and Immunology

Volumn 95, Issue 5, 2005, Pages 468-473

  Kobayashi, Michiko ^a   Thomassen, Mary Jane ^b   Rambasek, Todd ^b   Bonfield, Tracey L ^b   Raychaudhuri, Baisakhi ^b   Malur, Anagha ^b   Winkler, Aaron R ^a   Barna, Barbara P ^b   Goldman, Samuel J ^a   Kavuru, Mani S ^b  

^a PFIZER INC   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; EOSINOPHIL; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROVOCATION TEST; REAL TIME POLYMERASE CHAIN REACTION;

EID: 28044442756     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61173-8     Document Type: Article

References (31)

1. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol. 2004;22:789-815.
2. Elias JA, Lee CG, Zheng T, et al. New insights into the pathogenesis of asthma. J Clin Invest. 2003;111:291-297.
3. Rotondo D, Davidson J. Prostaglandin and PPAR control of immune cell function. Immunology. 2002;105:20-22.
4. Daynes RA, Jones DC. Emerging roles of PPARs in inflammation and immunity. Nature Rev Immunol. 2002;2:748-759.
5. Pershadsingh HA. Peroxisome proliferator-activated receptor-gamma: therapeutic target for diseases beyond diabetes: quo vadis? Expert Opin Investis Drugs. 2004;13:215-228.
6. Ricote M, Huang JT, Welch JS, Glass CK. The peroxisome proliferator-activated receptor-γ (PPARγ) as a regulator of monocyte/macrophage function. J Leukoc Biol. 1999;66:733-739.
7. Marx N, Froehlich J, Siam L, et al. Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2003;23:283-288.
8. Lewis JD, Lichtenstein GR, Stein RB, et al. An open-label trial of the PPARγ ligand rosiglitazone for active ulcerative colitis. Am J Gastroenterol. 2001;96:3323-3328.
9. Bonfield TL, Farver CF, Barna BP, et al. PPARγ is deficient in alveolar macrophages from patients with alveolar proteinosis. Am J Respir Cell Mol Biol. 2003;29:677-682.
10. Wang ACC, Dai X, Luu B, Conrad DJ. Peroxisome proliferator-activated receptor-γ regulates airway epithelial cell activation. Am J Respir Cell Mol Biol. 2001;164:688-693.
11. Benayoun L, Letuve S, Druilhe A, et al. Regulation of peroxisome proliferator-activated receptor γ expression in human asthmatic airways. Am J Respir Crit Care Med. 2001;164:1487-1494.
12. Culver DA, Barna BP, Raychaudhuri B, et al. PPARγ is deficient in alveolar macrophages in pulmonary sarcoidosis. Am J Respir Cell Mol Biol. 2004;30:1-5.
13. Asada K, Sasaki S, Suda T, Chida K, Nakamura H. Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages. Am J Respir Crit Care Med. 2004;169:195-200.
14. Patel HJ, Belvisi MG, Bishop-Bailey D, Yacoub MH, Mitchell JA. Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. J Immunol. 2003;170:2663-2669.
15. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature. 1998;391:79-82.
16. Valledor AF, Ricote M. Nuclear receptor signaling in macrophages. Biochem Pharmacol. 2004;67:201-212.
17. Honda K, Marquillies P, Capron M, Dombrowicz D. Peroxisome proliferator-activated receptor gamma is expressed in airways and inhibits features of airway remodeling in a mouse asthma model. J Allergy Clin Immunol. 2004;113:882-888.
18. Hammad H, de Heer HJ, Soullie T, et al. Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma. Am J Pathol. 2004;164;263-271.
19. Woerly G, Honda K, Loyens M, et al. Peroxisome proliferator-activated receptors (alpha) and (gamma) down-regulate allergic inflammation and eosinophil activation. J Exp Med. 2003;198:411-421.
20. Trifilieff A, Bench A, Hanley M, et al. PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independent effect. Br J Pharmacol. 2003;139:163-171.
21. Thomassen MJ, Raychaudhuri B, Dweik R, et al. Nitric oxide regulation of asthmatic airway inflammation with segmental allergen challenge. J Allergy Clin Immunol. 1999;104:1174-1182.
22. Chai H, Farr R, Froelich LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol. 1975;56:323-327.
23. Kavuru MS, Dweik R, Thomassen MJ. Role of bronchoscopy in asthma research. Clin Chest Med. 1999;20:153-189.
24. Thomassen MJ, Buhrow LT, Connors MJ, et al. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am J Respir Cell Mol Biol. 1997;17:279-283.
25. Calhoun WJ, Jarjour NN, Gleich GJ, Stevens CA, Busse WW. Increased airway inflammation with segmental versus aerosol antigen challenge. Am Rev Respir Dis. 1993;147:1465-1471.
26. Berger J, Moller DE. The mechanisms of action of PPARs. Ann Rev Med. 2002;53:409-435.
27. Mueller C, Weaver V, Vanden Heuvel JP, August A, Cantorna MT. Peroxisome proliferator-activated receptor gamma ligands attenuate immunological symptoms of experimental allergic asthma. Arch Biochem Biophys. 2003;418:186-196.
28. Hashimoto Y, Nakahara K. Improvement of asthma after administration of pioglitazone. Diabetes Care. 2002;25:401.
29. Kelly EA, Jarjour NN. Role of matrix metalloproteinases in asthma. Curr Opin Pulm Med. 2003;9:28-33.
30. Thomassen MJ, Follettie MT, Diesel V, et al. Increased MMP 12 expression revealed by microarray analysis in BAL cells from asthmatic patients following allergen challenge. Am J Respir Crit Care Med. 2004;169:A55.
31. Mariani TJ, Shapiro SD. PPARγ activators repress macrophage metalloelastase (MMP-12) expression. Am J Respir Crit Care Med. 2002;165:A239.